IL158082A0 - Amlodipine camsylate and methods for the preparation thereof - Google Patents

Amlodipine camsylate and methods for the preparation thereof

Info

Publication number
IL158082A0
IL158082A0 IL15808202A IL15808202A IL158082A0 IL 158082 A0 IL158082 A0 IL 158082A0 IL 15808202 A IL15808202 A IL 15808202A IL 15808202 A IL15808202 A IL 15808202A IL 158082 A0 IL158082 A0 IL 158082A0
Authority
IL
Israel
Prior art keywords
preparation
methods
amlodipine
amlodipine camsylate
camsylate
Prior art date
Application number
IL15808202A
Other languages
English (en)
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36792806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL158082(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of IL158082A0 publication Critical patent/IL158082A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IL15808202A 2001-03-29 2002-03-28 Amlodipine camsylate and methods for the preparation thereof IL158082A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2001-0016514A KR100452491B1 (ko) 2001-03-29 2001-03-29 신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
PCT/KR2002/000543 WO2002079158A1 (en) 2001-03-29 2002-03-28 Novel amlodipine camsylate and method for preparing thereof

Publications (1)

Publication Number Publication Date
IL158082A0 true IL158082A0 (en) 2004-03-28

Family

ID=36792806

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15808202A IL158082A0 (en) 2001-03-29 2002-03-28 Amlodipine camsylate and methods for the preparation thereof
IL158082A IL158082A (en) 2001-03-29 2003-09-24 Amlodipine camsylate and methods for the preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158082A IL158082A (en) 2001-03-29 2003-09-24 Amlodipine camsylate and methods for the preparation thereof

Country Status (22)

Country Link
US (1) US6936625B2 (de)
EP (1) EP1373207B1 (de)
JP (1) JP4188088B2 (de)
KR (1) KR100452491B1 (de)
CN (1) CN1238342C (de)
AT (1) ATE498612T1 (de)
AU (1) AU2002243069B2 (de)
BR (1) BRPI0208468B8 (de)
CA (1) CA2441613C (de)
CZ (1) CZ304489B6 (de)
DE (1) DE60239193D1 (de)
DK (1) DK1373207T3 (de)
ES (1) ES2360787T3 (de)
HK (1) HK1066545A1 (de)
HU (1) HU227919B1 (de)
IL (2) IL158082A0 (de)
MX (1) MXPA03008675A (de)
NZ (1) NZ528362A (de)
PL (1) PL207535B1 (de)
PT (1) PT1373207E (de)
RU (1) RU2241701C1 (de)
WO (1) WO2002079158A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135488A1 (en) * 2002-04-13 2007-06-14 Chung You S Amlodipine nicotinate and process for the preparation thereof
KR100496436B1 (ko) * 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100538641B1 (ko) 2002-07-30 2005-12-22 씨제이 주식회사 암로디핀의 유기산염
KR100462304B1 (ko) * 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR20040011751A (ko) * 2002-07-30 2004-02-11 씨제이 주식회사 암로디핀의 유기산염
JP2007528349A (ja) * 2003-01-27 2007-10-11 ハンミ ファーム. シーオー., エルティーディー. 高い安定性を有する無定形アムロジピンカムシレート、その製造方法及びこれを含む経口投与用組成物
WO2005042485A1 (en) * 2003-10-30 2005-05-12 Sk Chemicals, Co., Ltd. Acid added salts of amlodipine
KR100841409B1 (ko) * 2003-12-16 2008-06-25 에스케이케미칼주식회사 암로디핀 겐티세이트 염과 이의 제조방법
KR100632470B1 (ko) * 2005-02-25 2006-10-12 민연식 결정성 시부트라민 캄실레이트염과 이의 제조방법
KR100913791B1 (ko) * 2006-07-21 2009-08-26 한미약품 주식회사 (s)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물
KR100830003B1 (ko) 2006-10-31 2008-05-15 씨제이제일제당 (주) 결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법
KR100843401B1 (ko) * 2006-12-04 2008-07-04 씨제이제일제당 (주) 결정성 s-(-)-암로디핀 캠실레이트 무수물 및 이의제조방법
KR100840069B1 (ko) * 2007-01-23 2008-06-20 씨제이제일제당 (주) 결정성 s-(-)-암로디핀 오로테이트 무수물 및 이의제조방법
KR100799821B1 (ko) * 2007-02-05 2008-01-31 동화약품공업주식회사 신규한 이마티닙 캠실레이트 및 그의 제조방법
CA2749903C (en) * 2009-01-23 2016-09-06 Jae Hyun Park Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
DK3150610T3 (da) 2010-02-12 2019-11-04 Pfizer Salte og polymorfer af 8-fluor-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-on
US8415483B2 (en) 2010-12-22 2013-04-09 Astrazeneca Ab Compounds and their use as BACE inhibitors
CN102266333B (zh) * 2011-08-19 2012-08-29 海南锦瑞制药股份有限公司 一种含有左旋氨氯地平和阿托伐他汀钙的全新药用组合物及其制备方法
US9650336B2 (en) 2011-10-10 2017-05-16 Astrazeneca Ab Mono-fluoro beta-secretase inhibitors
US10548882B2 (en) * 2012-06-21 2020-02-04 Astrazeneca Ab Camsylate salt
KR101910901B1 (ko) 2013-11-29 2018-10-24 한미약품 주식회사 암로디핀, 로자탄 및 로수바스타틴을 포함하는 약제학적 복합 제제
KR101914930B1 (ko) 2015-03-31 2018-11-05 한미약품 주식회사 암로디핀, 로자탄 및 클로르탈리돈을 포함하는 약제학적 복합 제제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
KR100188391B1 (ko) 1993-08-27 1999-06-01 류정열 전기자동차의 충전중 표시 장치
KR100374405B1 (ko) 2000-06-21 2003-03-04 한국유나이티드제약 주식회사 암로디핀 베실레이트의 제조방법
CA2433181C (en) * 2000-12-29 2005-11-22 Pfizer Limited Amlodipine hemifumarate

Also Published As

Publication number Publication date
PL362667A1 (en) 2004-11-02
PT1373207E (pt) 2011-03-01
BR0208468B1 (pt) 2017-10-31
HK1066545A1 (en) 2005-03-24
EP1373207A4 (de) 2009-01-21
JP4188088B2 (ja) 2008-11-26
AU2002243069B2 (en) 2004-10-14
BRPI0208468B8 (pt) 2021-05-25
PL207535B1 (pl) 2010-12-31
HUP0303639A2 (hu) 2004-03-01
RU2241701C1 (ru) 2004-12-10
US20040116478A1 (en) 2004-06-17
CA2441613C (en) 2009-02-03
DK1373207T3 (da) 2011-05-30
RU2003131687A (ru) 2005-02-27
CZ304489B6 (cs) 2014-05-28
EP1373207B1 (de) 2011-02-16
CZ20032583A3 (cs) 2004-01-14
JP2004534008A (ja) 2004-11-11
HUP0303639A3 (en) 2007-05-02
CN1238342C (zh) 2006-01-25
CN1501916A (zh) 2004-06-02
US6936625B2 (en) 2005-08-30
ATE498612T1 (de) 2011-03-15
DE60239193D1 (de) 2011-03-31
MXPA03008675A (es) 2003-12-12
WO2002079158A1 (en) 2002-10-10
ES2360787T3 (es) 2011-06-09
IL158082A (en) 2009-07-20
BR0208468A (pt) 2004-03-02
KR100452491B1 (ko) 2004-10-12
HU227919B1 (en) 2012-06-28
CA2441613A1 (en) 2002-10-10
KR20020076561A (ko) 2002-10-11
NZ528362A (en) 2005-04-29
EP1373207A1 (de) 2004-01-02

Similar Documents

Publication Publication Date Title
IL158082A0 (en) Amlodipine camsylate and methods for the preparation thereof
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
ATE332639T1 (de) Herbizidzusammensetzung,umfassend herbizide verbindung in säureform und ansäuerndes mittel, applizierverfahren und herstellungsverfahren davon
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
MY128609A (en) Ccr5 antagonists useful for treating aids.
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
WO2007078848A3 (en) Preparation of pharmaceutical salts of 3-o-(3',3'-dimethlsuccinyl) betulinic acid
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
HK1090062A1 (en) Colchicoside analogues
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
WO2006074919A3 (de) 3 -AMINO- 6-ARYL (BZW.6-HETEROARYL) -THIENO [2 , 3-B] PYRIDIN-2-CARBONSÄUREAMIDE, DIESE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN UND IHRE VERWENDUNG ALS INHIBITOREN DER TNFα-FREISETZUNG
AU2003256108A1 (en) Organic acid salt of amlodipine
EP1694645A4 (de) Amlodipin-gentisat und verfahren zu dessen herstellung
WO2001081298A3 (en) Cyclic carboxylic acids as integrin antagonists
NO20061290L (no) Nye forbindelser
PT1218401E (pt) 4-benzilaminoquinolinas conjugadas com acido biliar e seus heterociclicos metodos de sua producao medicamentos contendo estes compostos e sua aplicacao
WO2004072037A8 (en) 2,3'-bipyridines derivatives as selective cox-2 inhibitors
WO2003004460A3 (en) Succinic acid derivatives
WO2002030874A3 (en) Aliphatic, cyclic amino carboxylic acids as integrin antagonists
WO2003013530A3 (de) Salze substituierter 1,2,3,4,-tetrahydrochinolin-2-carbonsaurederivate als nmda-antagonisten
EP1710235A4 (de) Extrakte von marasmins androsaceus l.es, piperdinonderivate und die verwendung als blutdrucksenkende mittel
ATE401081T1 (de) Ammoniumsalze von ornithin-derivaten zur behandlung von enzündlichen erkrankungen
WO2002030876A3 (en) Cyclic carboxylic acids as integrin antagonists
TW200514557A (en) Pharmaceutically acceptable salt of amlodipine and method of preparing the same